Kangmei Pharmaceutical Market Cap

Kangmei Pharmaceutical has a market cap or net worth of 28.07 billion as of October 20, 2025. Its market cap has increased by 17.73% in one year.

Market Cap

28.07B

Enterprise Value

27.34B

Revenue

5.29B

Ranking

n/a

PE Ratio

2,889.70

Stock Price

2.04

Market Cap Chart

Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 28.07B, an increase of 988.71%. That is a compound annual growth rate of 10.19%.

Market Cap History

Date	Market Cap	% Change
Oct 20, 2025	28.07B	-13.47%
Dec 31, 2024	32.44B	25.81%
Dec 29, 2023	25.79B	-15.45%
Dec 30, 2022	30.50B	-28.80%
Dec 31, 2021	42.84B	221.38%
Dec 31, 2020	13.33B	-28.15%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	433.20B
WuXi AppTec	284.61B
Shenzhen Mindray Bio-Medical Electronics	272.72B
Sichuan Biokin Pharmaceutical	142.05B
Zhangzhou Pientzehuang Pharmaceutical.,	118.46B
Shanghai United Imaging Healthcare	117.99B
Aier Eye Hospital Group	116.66B
Yunnan Baiyao Group Co.,Ltd	101.81B

Market Cap Rankings